Skip to main content
SpringerLink
Log in

Infection par le VIH

  • Chapter
Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques

  • 663 Accesses

Abstrait

Le développement d’une épidémie de maladie de Kaposi chez les patients homosexuels de la côte ouest des États-Unis a été à l’origine de lamise en évidence d’une nouvelle maladie, le syndrome d’immunodéficience acquise (SIDA), et de la découverte du virus de l’immunodéficience humaine (VIH).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42:418–427.

    Article  PubMed  CAS  Google Scholar 

  2. Chaix ML, Descamps D, Harzic M et al. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 2003; 17:2635–2643.

    Article  PubMed  Google Scholar 

  3. Lacabaratz-Porret C, Urrutia A, Doisne JM et al. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV) specific T cell responses in primary HIV infection. J Infect Dis 2003; 187:748–757.

    Article  PubMed  CAS  Google Scholar 

  4. Wilkins K, Turner R, Dolev JC et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol 2006;54:189–206.

    Article  PubMed  Google Scholar 

  5. Beylot-Barry M, Vergier B, Masquelier B et al. The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol 1999; 23:1208–1216.

    Article  PubMed  CAS  Google Scholar 

  6. Hausermann P, Khanna N, Buess M et al. Cutaneous plasmablastic lymphoma in an HIV-positivemale: an unrecognized cutaneous manifestation. Dermatology 2004; 208:287–290.

    Article  PubMed  CAS  Google Scholar 

  7. Pulik M, Lionnet F, Genet P et al. Acute myelocytic leukemia in immunodeficiency virus infection. Ann Med Interne (Paris) 1998; 149:475–478.

    CAS  Google Scholar 

  8. Kreuter A, Brockmeyer NH, Hochdorfer B et al. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 2005; 52:603–608.

    Article  PubMed  Google Scholar 

  9. Matichard E, Descamps V, Grossin M et al. Merkel cell carcinoma in a black human immunodeficiency virus-infected patient. Br J Dermatol 2002; 146:671–673.

    Article  PubMed  CAS  Google Scholar 

  10. O’Moore EJ, Nandawni R, Uthayakumar S et al. HIV-associated granuloma annulare (HAGA): a report of six cases. Br J Dermatol 2000; 142:1054–1056.

    Article  PubMed  Google Scholar 

  11. Toro JR, Chu P, Yen TS, LeBoit PE. Granuloma annulare and human immunodeficiency virus infection. Arch Dermatol 1999; 135:1341–1346.

    Article  PubMed  CAS  Google Scholar 

  12. Penas PF, Jones-Caballero M, García-Díez A. Association between zalcitabine therapy for human immunodeficiency virus and granuloma annulare? Arch Dermatol 2001; 137:964.

    PubMed  CAS  Google Scholar 

  13. Ball RA, Kinchelow T, ISR Substudy Group. Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide. J Am Acad Dermatol 2003;49:826–831.

    Article  PubMed  Google Scholar 

  14. Resneck JS, Van Beek M, Furmanski L et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 2004; 292:2614–2621.

    Article  PubMed  CAS  Google Scholar 

  15. Magro CM, Crowson AN. Necrotizing eosinophilic folliculitis as a manifestation of the atopic diathesis. Int J Dermatol 2000; 39:672–677.

    Article  PubMed  CAS  Google Scholar 

  16. Rajendran PM, Dolev JC, Heaphy MR Jr, Maurer T. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 2005; 141:1227–1231.

    Article  PubMed  Google Scholar 

  17. Viraben R, Dupre A. Lichenoid granulomatous papular dermatosis associatedwith human immunodeficiency virus infection: an immunohistochemical study. J Am Acad Dermatol 1988;18:1140–1141.

    Article  PubMed  CAS  Google Scholar 

  18. Campisi G, Di Fede O, Crax A et al. Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity. J Am Acad Dermatol 2004; 51:364–370.

    Article  PubMed  CAS  Google Scholar 

  19. Simonitsch I, Geusau A, Chott A, Jurecka W. Cutaneous dendritic cells are main targets in acute HIV-1-infection. Mod Pathol 2000; 13:1232–1237.

    Article  PubMed  CAS  Google Scholar 

  20. Rongioletti F, Ghigliotti G, De Marchi R, Rebora A. Cutaneous mucinoses and HIV infection. Br J Dermatol 1998; 139:1077–1080.

    Article  PubMed  CAS  Google Scholar 

  21. Mendez M, Rossetti MV, Del C Batlle AM, Parera VE. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. J Am Acad Dermatol 2005; 52:417–424.

    Article  PubMed  Google Scholar 

  22. Calza L, Manfredi R, Colangeli V et al. Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 2003; 14:356–359.

    Article  PubMed  Google Scholar 

  23. Empson M, Bishop GA, Nightingale B, Garsia R. Atopy, anergic status, and cytokine expression in HIV-infected subjects. J Allergy Clin Immunol 1999; 103:833–842.

    Article  PubMed  CAS  Google Scholar 

  24. Viraben R, Aquilina C, Cambon L, Bazex J. Allergic contact dermatitis in HIV-positive patients. Contact Dermatitis 1994; 31:326–327.

    Article  PubMed  CAS  Google Scholar 

  25. Trope BM, Lenzi ME. AIDS and HIV infections: uncommon presentations. Clin Dermatol 2005; 23:572–580.

    Article  PubMed  Google Scholar 

  26. Miralles ES, Nunez M, De Las Heras ME et al. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995;133:990–993.

    Article  PubMed  CAS  Google Scholar 

  27. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol 2004; 22:487–498.

    Article  PubMed  Google Scholar 

  28. Aquilina C, Viraben R, Sire S. Ivermectinresponsive Demodex infestation during human immunodeficiency virus infection. A case report and literature review. Dermatology 2002;205:394–397.

    Article  PubMed  CAS  Google Scholar 

  29. Gaitan-Cepeda LA, Martinez-Gonzalez M, Ceballos-Salobrena A. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART. AIDS Patient Care STDS 2005; 19:70–77.

    Article  PubMed  Google Scholar 

  30. Pappas PG, Rex JH, Sobel JD et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161–189.

    Article  PubMed  Google Scholar 

  31. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321:794–799.

    PubMed  CAS  Google Scholar 

  32. Cohen PR, Bank DE, Silvers DN, Grossman ME. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virusinfected patients. J Am Acad Dermatol 1990; 23:422–428.

    Article  PubMed  CAS  Google Scholar 

  33. Torssander J, Karlsson A, Morfeldt-Manson L et al. Dermatophytosis and HIV infection. A study in homosexual men. Acta Derm Venereol 1988; 68:53–56.

    PubMed  CAS  Google Scholar 

  34. Maniar JK, Chitale AR, Miskeen A et al. Penicillium marneffei infection: an AIDS-defining illness. Indian J Dermatol Venereol Leprol 2005;71:202–204.

    Article  PubMed  CAS  Google Scholar 

  35. Walling DM, Etienne W, Ray AJ et al. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia. J Infect Dis 2004; 190:387–395.

    Article  PubMed  CAS  Google Scholar 

  36. Walling DM, Flaitz CM, Nichols CM. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valaciclovir. J Infect Dis 2003;188:883–890.

    Article  PubMed  CAS  Google Scholar 

  37. Manchanda Y, Sethuraman G, Paderwani PP et al. Molluscum contagiosum presenting as penile horn in an HIV positive patient. Sex Transm Infect 2005; 81:183–184.

    Article  PubMed  CAS  Google Scholar 

  38. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45–52.

    Article  PubMed  Google Scholar 

  39. Popara M, Pendle S, Sacks L et al. Varicella pneumonia in patients with HIV/AIDS. Int J Infect Dis 2002; 6:6–8.

    Article  PubMed  Google Scholar 

  40. Breton G, Fillet AM, Katlama C et al. Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy. Clin Infect Dis 1998;27:1525–1527.

    Article  PubMed  CAS  Google Scholar 

  41. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823–1830.

    Article  Google Scholar 

  42. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med 2000; 342:1027–1038.

    Article  PubMed  CAS  Google Scholar 

  43. Plancoulaine S, Abel L, van Beveren M et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000; 356:1062–1065.

    Article  PubMed  CAS  Google Scholar 

  44. Wilkinson J, Cope A, Gill J et al. Identification of Kaposi’s sarcoma-associated herpes-virus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J Virol 2002; 76:2634–2640.

    Article  PubMed  CAS  Google Scholar 

  45. Morganroth GS. Topical 0,1% alitretinoin gel for classic Kaposi sarcoma. Arch Dermatol 2002; 138:542–543.

    Article  PubMed  Google Scholar 

  46. Rosenthal E, Poizot-Martin I, Saint-Marc T et al. Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. Am J Clin Oncol 2002; 25:57–59.

    Article  PubMed  Google Scholar 

  47. Gill PS, Tulpule A, Espina BM et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi’s sarcoma. J Clin Oncol 1999; 17:1876–1883.

    PubMed  CAS  Google Scholar 

  48. Little RF, Merced-Galindez F, Staskus K et al. A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis 2003; 187:149–153.

    Article  PubMed  CAS  Google Scholar 

  49. Horsburgh CR Jr. Epidemiology of mycobacterial diseases in AIDS. Res Microbiol 1992;143:372–377.

    Article  PubMed  Google Scholar 

  50. Bachelez H, Ducloy G, Pinquier L et al. Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient. Br J Dermatol 1996; 134:801–803.

    Article  PubMed  CAS  Google Scholar 

  51. Piketty C, Danic DL, Weiss L et al. Sporotrichosislike infection caused by Mycobacterium avium in the acquired immunodeficiency syndrome. Arch Dermatol 1993; 129:1343–1344.

    Article  PubMed  CAS  Google Scholar 

  52. Volpe F, Schwimmer A, Barr C. Oral manifestation of disseminated Mycobacterium avium intracellulare in a patient with AIDS. Oral Surg Oral Med Oral Pathol 1985; 60:567–570.

    Article  PubMed  CAS  Google Scholar 

  53. Tappe D, Langmann P, Zilly M et al. Osteomyelitis and skin ulcers caused by Mycobacterium szulgai in an AIDS patient. Scand J Infect Dis 2004; 36:883–885.

    Article  PubMed  Google Scholar 

  54. Catorze G, Alberto J, Afonso A et al. Leishmania infantum/HIV co-infection: cutaneous lesions following treatment of visceral leishmaniasis. Ann Dermatol Venereol 2006; 133:39–42.

    Article  PubMed  CAS  Google Scholar 

  55. Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol 2003; 97Suppl 1:107–114.

    Article  PubMed  Google Scholar 

  56. Gonzalez-Martin G, Yanez CG, Gonzalez-Contreras L, Labarca J. Adverse drug reactions (ADRs) in patients with HIV infection. A prospective study. Int J Clin Pharmacol Ther 1999; 37:34–40.

    PubMed  CAS  Google Scholar 

  57. Aquilina C, Viraben R, Roueire A. Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor. Arch Intern Med 1998; 158:2160–2161.

    Article  PubMed  CAS  Google Scholar 

  58. Kong HH, Myers C. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients. Dermatol Ther 2005; 18:58–66.

    Article  PubMed  Google Scholar 

  59. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN et al. Euro SCAR Study Group. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 15:1843–1848.

    Article  PubMed  CAS  Google Scholar 

  60. Chirouze C, Hustache-Mathieu L, Rougeot C et al. Risk factors for Abacavir-induced hypersensibility syndrome in the « real world ». Pathol Biol (Paris) 2004; 52:529–533.

    CAS  Google Scholar 

  61. Aquilina C, Mularczyk M, Lucas F, Viraben R. Unusual clinical presentation of hypersensitivity reaction to abacavir. AIDS 2003; 17:2403–2404.

    Article  PubMed  Google Scholar 

  62. Phillips EJ, Wong GA, Kaul R et al. Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 2005; 19:979–981.

    Article  PubMed  CAS  Google Scholar 

  63. Milpied-Homsi B et al. Skin testing to investigate cutaneous adverse reactions of antiretroviral drugs. 8th European Conference on Clinical Aspects and Treatment of HIV-infection. Athens, 28–31 october 2001 (abstract P137).

    Google Scholar 

  64. Nucera E, Schiavino D, Buonomo A et al. Tolerance induction to cotrimoxazole. Allergy 2000; 55:681–682.

    Article  PubMed  CAS  Google Scholar 

  65. Eliaszewicz M, Flahault A, Roujeau JC et al. Epitox Study Group. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J Am Acad Dermatol 2002; 47:40–46.

    Article  PubMed  Google Scholar 

  66. Jain RG, Furfine ES, Pedneault L et al. Metabolic complications associated with antiretroviral therapy. Antiviral Res 2001; 51:151–177.

    Article  PubMed  CAS  Google Scholar 

  67. Bastard JP, Caron M, Vidal H et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002; 359:1026–1031.

    Article  PubMed  CAS  Google Scholar 

  68. Jones SP, Janneh O, Back DJ, Pirmohamed M. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors. Antivir Ther 2005; 10:207–213.

    PubMed  CAS  Google Scholar 

  69. Cherry CL, Gahan ME, McArthur JC et al. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr 2002; 30:271–277.

    PubMed  CAS  Google Scholar 

  70. Levan P, Nguyen TH, Lallemand F et al. Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue. AIDS 2002;16:1985–1987.

    Article  PubMed  Google Scholar 

  71. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52:233–239.

    Article  PubMed  Google Scholar 

  72. Wu JJ, Huang DB, Pang KR, Tyring SK. Selected sexually transmitted diseases and their relationship to HIV. Clin Dermatol 2004; 22:499–508.

    Article  PubMed  Google Scholar 

  73. Buchacz K, Patel P, Taylor M et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18:2075–2079.

    Article  PubMed  Google Scholar 

  74. Zhang J, Li G, Bafica A et al. Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1. J Immunol 2005; 174:7995–8002.

    PubMed  CAS  Google Scholar 

  75. Van der Bij AK, Spaargaren J, Morre SA et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis 2006; 42:186–194.

    Article  PubMed  Google Scholar 

  76. Smits PH, Bakker R, Jong E et al. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infectedmen. JClin Microbiol 2005;43:5936–5939.

    Article  Google Scholar 

  77. Moussa R, Stephenson I, Fisk P et al. Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome? AIDS 2004; 18:1221–1223.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Dermatologie et de Médecine sociale, Hôpital La Grave, Place Lange, 31059, Toulouse CEDEX 9

    Christian Aquilina (Praticien hospitalier) & Roland Viraben (Praticien hospitalier)

Authors
  1. Christian Aquilina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Viraben
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Aquilina, C., Viraben, R. (2008). Infection par le VIH. In: Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques. Springer, Paris. https://doi.org/10.1007/978-2-287-48494-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-48494-0_13

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-48493-3

  • Online ISBN: 978-2-287-48494-0

Publish with us

Policies and ethics

Search

Navigation